Literature DB >> 23474700

Preoperative liver function assessments to estimate the prognosis and safety of liver resections.

Toru Mizuguchi1, Masaki Kawamoto, Makoto Meguro, Thomas T Hui, Koichi Hirata.   

Abstract

Liver function assessment is important to ensure safe surgical procedures in patients with hepatocellular disease. Because the liver influences a wide variety of functions, including protein synthesis and metabolic, immune and storage functions, no single parameter is sufficient to adequately address all of these functions. We reviewed the relevant literature concerning the scoring systems, functional tests, plasma parameters and imaging modalities currently used to evaluate the liver function in an attempt to determine which parameters provide the most comprehensive and useful results. While the Child-Pugh scoring system is the gold standard for liver disease assessment, the liver damage grading system recommended by the Liver Cancer Study Group of Japan is also useful. Various models for end-stage liver disease scoring are used for organ allocation. While the indocyanine green clearance test is widely accepted throughout the world, other assessments have not been used routinely for clinical evaluations. The levels of plasma proteins, including albumin, prealbumin, retinol binding protein, apolipoprotein, coagulation factors and antithrombin III, represent the liver productivity. Liver fibrotic markers also correlate with liver function. Imaging modalities such as (99m)Tc-galactosyl serum albumin scintigraphy, (99m)Tc-mebrofenin hepatobiliary scintigraphy and transient elastography are also available, but future studies are needed to validate their clinical efficacy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474700     DOI: 10.1007/s00595-013-0534-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  62 in total

1.  Comparison of the grade evaluated by "Liver damage" of Liver Cancer Study Group of Japan and Child-Pugh classification in patients with hepatocellular carcinoma.

Authors:  Katsuhisa Omagari; Kazuo Ohba; Yoshiko Kadokawa; Hiroaki Hazama; Jun-Ichi Masuda; Hideki Kinoshita; Isao Matsuo; Ken Ohnita; Yohei Mizuta; Kenji Hayashida; Shigeru Kohno
Journal:  Hepatol Res       Date:  2006-02-03       Impact factor: 4.288

Review 2.  Surgery and portal hypertension.

Authors:  C G Child; J G Turcotte
Journal:  Major Probl Clin Surg       Date:  1964

3.  Cluster analysis of indicators of liver functional and preoperative low branched-chain amino acid tyrosine ration indicate a high risk of early recurrence in analysis of 165 hepatocellular carcinoma patients after initial hepatectomy.

Authors:  Yukio Nakamura; Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Kohei Harada; Shigenori Ota; Koichi Hirata
Journal:  Surgery       Date:  2011-08       Impact factor: 3.982

4.  Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers.

Authors:  Masaki Kawamoto; Toru Mizuguchi; Tadashi Katsuramaki; Minoru Nagayama; Hideki Oshima; Hiroyuki Kawasaki; Takayuki Nobuoka; Yasutoshi Kimura; Koichi Hirata
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

Review 5.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

6.  Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy.

Authors:  Toru Mizuguchi; Tadashi Katsuramaki; Takayuki Nobuoka; Masaki Kawamoto; Hideki Oshima; Hiroyuki Kawasaki; Hitoshi Kikuchi; Chihiro Shibata; Koichi Hirata
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

7.  Surgical treatment of hepatocellular carcinoma.

Authors:  Jacques Belghiti; Reza Kianmanesh
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

8.  Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy.

Authors:  Roelof J Bennink; Sander Dinant; Deha Erdogan; Bob H Heijnen; Irene H Straatsburg; Arlene K van Vliet; Thomas M van Gulik
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

9.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

10.  The catabolic fate of hyaluronic acid.

Authors:  T C Laurent; I M Dahl; L B Dahl; A Engström-Laurent; S Eriksson; J R Fraser; K A Granath; C Laurent; U B Laurent; K Lilja
Journal:  Connect Tissue Res       Date:  1986       Impact factor: 3.417

View more
  21 in total

1.  Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization.

Authors:  Maciej Malinowski; Johan Friso Lock; Daniel Seehofer; Bernhard Gebauer; Antje Schulz; Lina Demirel; Jan Bednarsch; Victoria Stary; Peter Neuhaus; Martin Stockmann
Journal:  Surg Today       Date:  2015-12-31       Impact factor: 2.549

2.  Opportunistic use of a Foley catheter to provide a common electrocautery with a water-irrigating channel for hepatic parenchymal transection.

Authors:  Yuzo Yamamoto; Masato Yoshioka; Go Watanabe; Hiroshi Uchinami
Journal:  Surg Today       Date:  2015-03-24       Impact factor: 2.549

Review 3.  Indications, limitations and maneuvers to enable extended hepatectomy: current trends.

Authors:  Dimitrios Dimitroulis; Petros Tsaparas; Serena Valsami; Dimitrios Mantas; Eleftherios Spartalis; Charalampos Markakis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

4.  Potential of Gd-EOB-DTPA-enhanced MR imaging for evaluation of bile duct ligation-induced liver injury in rabbits.

Authors:  Ying Ding; Sheng-Xiang Rao; Caizhong Chen; Renchen Li; Meng-Su Zeng
Journal:  Hepatol Int       Date:  2014-12-06       Impact factor: 6.047

5.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.

Authors:  Federico Tomassini; Mariano C Giglio; Giuseppe De Simone; Roberto Montalti; Roberto I Troisi
Journal:  Updates Surg       Date:  2020-08-04

Review 6.  Indocyanine green kinetics to assess liver function: Ready for a clinical dynamic assessment in major liver surgery?

Authors:  Andrea De Gasperi; Ernestina Mazza; Manlio Prosperi
Journal:  World J Hepatol       Date:  2016-03-08

7.  Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.

Authors:  Hiroshi Wada; Hidetoshi Eguchi; Hiroaki Nagano; Shoji Kubo; Takuya Nakai; Masaki Kaibori; Michihiro Hayashi; Shigekazu Takemura; Shogo Tanaka; Yasuyuki Nakata; Kosuke Matsui; Morihiko Ishizaki; Fumitoshi Hirokawa; Koji Komeda; Kazuhisa Uchiyama; Masanori Kon; Yuichiro Doki; Masaki Mori
Journal:  Surg Today       Date:  2017-06-08       Impact factor: 2.549

8.  Use of magnetic resonance elastography for assessing liver functional reserve: A clinical study.

Authors:  Bin Li; Jie Min; Wei-Ren Liang; Guang-Qiang Zhang; Jian-Jun Wu; Kai Jin; Wei Huang; Cai-Yu Ying; Ming Chao
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 9.  Impact of aging on morbidity and mortality after liver resection: a systematic review and meta-analysis.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Kenji Okita; Shigenori Ota; Masayuki Ishii; Tomomi Ueki; Toshihiko Nishidate; Yasutoshi Kimura; Tomohisa Furuhata; Koichi Hirata
Journal:  Surg Today       Date:  2014-02-14       Impact factor: 2.549

10.  Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?

Authors:  Thiery Chapelle; Bart Op De Beeck; Ivan Huyghe; Sven Francque; Ann Driessen; Geert Roeyen; Dirk Ysebaert; Kathleen De Greef
Journal:  HPB (Oxford)       Date:  2016-03-21       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.